These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16199918)

  • 1. [Clinically significant drug-drug and drug-food interactions associated with calcium channel blockers].
    Imaura M; Ohno Y; Nakajima K; Suzuki H
    Clin Calcium; 2005 Oct; 15(10):1709-16. PubMed ID: 16199918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions of the most frequently used drugs in the treatment of angina pectoris].
    Miljković M; Tanasijević G
    Srp Arh Celok Lek; 1997; 125(3-4):116-23. PubMed ID: 9221519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of grapefruit juice and calcium channel blockers.
    Sica DA
    Am J Hypertens; 2006 Jul; 19(7):768-73. PubMed ID: 16814135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium inhibitors. Principles and rules of use].
    Thuillez C
    Rev Prat; 1993 May; 43(9):1159-66. PubMed ID: 8378729
    [No Abstract]   [Full Text] [Related]  

  • 5. Adriamycin cardiotoxicity and calcium entry blockers: the need for caution in the combination.
    Rabkin SW; Godin DV
    Can J Cardiol; 1985; 1(5):IV-VII. PubMed ID: 3021301
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S; Weber M
    Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting calcium antagonists linked to CV adverse events.
    Geriatrics; 2000 Nov; 55(11):24. PubMed ID: 11086469
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atrioventricular complete heart block developed due to verapamil use together with honey consumption].
    Onrat E; Kaya D; Barutçu I
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):353-4. PubMed ID: 14675888
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations.
    Parati G
    J Cardiovasc Pharmacol; 2009 May; 53(5):352-8. PubMed ID: 19365281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug interactions with calcium antagonists].
    Stricker M
    Schweiz Rundsch Med Prax; 1985 May; 74(19):514-6. PubMed ID: 4012135
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-nutrient interactions in elderly people.
    Akamine D; Filho MK; Peres CM
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):304-10. PubMed ID: 17414499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food-drug interactions.
    Cheng TO
    Int J Cardiol; 2006 Jan; 106(3):392-3. PubMed ID: 16337049
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of DNA-damaging N-nitroso compounds from the interaction of calcium-channel blockers with nitrite.
    Martelli A; Robbiano L; Grossi S; Mattioli F; Brambilla G
    Toxicology; 2007 Sep; 238(2-3):211-5. PubMed ID: 17644234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the essentials of drug interactions: a potential need for safe and effective use of drugs.
    Bista D; Palaian S; Shankar PR; Prabhu MM; Paudel R; Mishra P
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):421-30. PubMed ID: 18604069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chronic stable angina pectoris.
    Rodríguez-Ospina L; Montano-Soto L
    Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.